These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 21788139

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Novel design principle validated: glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent.
    Somsák L, Nagy V, Vidal S, Czifrák K, Berzsényi E, Praly JP.
    Bioorg Med Chem Lett; 2008 Oct 15; 18(20):5680-3. PubMed ID: 18793852
    [Abstract] [Full Text] [Related]

  • 23. Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening.
    Postigo MP, Guido RV, Oliva G, Castilho MS, da R Pitta I, de Albuquerque JF, Andricopulo AD.
    J Chem Inf Model; 2010 Sep 27; 50(9):1693-705. PubMed ID: 20695479
    [Abstract] [Full Text] [Related]

  • 24. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity.
    Wang Y, Yan Z, Guo Y, Zhang L.
    Future Med Chem; 2021 May 27; 13(10):897-909. PubMed ID: 33906369
    [Abstract] [Full Text] [Related]

  • 25. Discovery of new nanomolar inhibitors of GPa: Extension of 2-oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors.
    Loughlin WA, Jenkins ID, Karis ND, Healy PC.
    Eur J Med Chem; 2017 Feb 15; 127():341-356. PubMed ID: 28076824
    [Abstract] [Full Text] [Related]

  • 26. Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents.
    Singh N, Pandey SK, Anand N, Dwivedi R, Singh S, Sinha SK, Chaturvedi V, Jaiswal N, Srivastava AK, Shah P, Siddiqui MI, Tripathi RP.
    Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4404-8. PubMed ID: 21737274
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses.
    Liu G, Zhang Z, Luo X, Shen J, Liu H, Shen X, Chen K, Jiang H.
    Bioorg Med Chem; 2004 Aug 01; 12(15):4147-57. PubMed ID: 15246091
    [Abstract] [Full Text] [Related]

  • 34. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.
    Cheng K, Liu J, Sun H, Xie J.
    Chem Biodivers; 2010 Mar 01; 7(3):690-7. PubMed ID: 20232331
    [Abstract] [Full Text] [Related]

  • 35. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
    Goyard D, Kónya B, Chajistamatiou AS, Chrysina ED, Leroy J, Balzarin S, Tournier M, Tousch D, Petit P, Duret C, Maurel P, Somsák L, Docsa T, Gergely P, Praly JP, Azay-Milhau J, Vidal S.
    Eur J Med Chem; 2016 Jan 27; 108():444-454. PubMed ID: 26708111
    [Abstract] [Full Text] [Related]

  • 36. Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.
    Krimm I, Lancelin JM, Praly JP.
    J Med Chem; 2012 Feb 09; 55(3):1287-95. PubMed ID: 22229710
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. 3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents.
    Saqib U, Siddiqi MI.
    SAR QSAR Environ Res; 2009 Jul 09; 20(5-6):519-35. PubMed ID: 19916112
    [Abstract] [Full Text] [Related]

  • 39. Modeling aided design of potent glycogen phosphorylase inhibitors.
    Deng Q, Lu Z, Bohn J, Ellsworth KP, Myers RW, Geissler WM, Harris G, Willoughby CA, Chapman K, McKeever B, Mosley R.
    J Mol Graph Model; 2005 Apr 09; 23(5):457-64. PubMed ID: 15781188
    [Abstract] [Full Text] [Related]

  • 40. New inhibitors of glycogen phosphorylase as potential antidiabetic agents.
    Somsák L, Czifrák K, Tóth M, Bokor E, Chrysina ED, Alexacou KM, Hayes JM, Tiraidis C, Lazoura E, Leonidas DD, Zographos SE, Oikonomakos NG.
    Curr Med Chem; 2008 Apr 09; 15(28):2933-83. PubMed ID: 19075645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.